logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Ribo Biotech-B (06938.HK) repurchased 181,600 shares for approximately HK$9.3316 million on September 16.

date
16/09/2026
Zhitong Finance APP news, Ribo Biotech-B (06938.HK) announced that on September 16, 2026, the company spent approximately HK$9.3316 million to repurchase 181,600 shares at a repurchase price of HK$49.96 to HK$52 per share.
Latest
2 m ago
AI-RAN technology commercialization accelerates + UK defense cooperation deepens! Nokia (NOK.US) rises in pre-market trading in response
2 m ago
Yanpai Co., Ltd. (301081.SZ) actual controller Sun Shiyan plans to reduce holdings by no more than 1.2799% of shares.
5 m ago
Metro Design (003013.SZ) director Wang Jian plans to reduce holdings by 8,000 shares of the company's stock.
8 m ago
Invt (002334.SZ) grants 940,000 restricted shares and 730,000 stock options to incentive recipients.
8 m ago
KPMG: China's smart wearable market reached 105.3 billion yuan in 2025, with a compound annual growth rate of 11%.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.